Tuesday, December 23, 2014

Myriad Loses DNA Patent Case

Diagnostics: Appeals court says tests for breast and ovarian cancer genes are not patent-eligible



via Chemical & Engineering News: Biological SCENE http://ift.tt/1E9buHX
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)